Plicator II
Commercial- Indications
- Gastroesophageal reflux disease
Company intelligence / Profile preview
NDO Surgical
Mansfield, Massachusetts, United Statesbiospace.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
NDO Surgical developed and commercialized the Plicator System, a minimally invasive endoscopic device for treating GERD. Clinical studies demonstrated reduction in GERD symptoms and medication use with long-term follow-up data supporting efficacy. However, there is no evidence of ongoing clinical development or commercialization as of recent years.
- Therapeutic areas
- Gastroenterology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Surgical Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on NDO Surgical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NDO Surgical.